Creasy, Caretha L
Article History
First Online: 7 April 2017
Competing interests
: C.L.C. is an employee and stock owner of GSK, a company with compounds in clinical development for both EZH2 and BET. The two articles that are summarized in the News & Views article indicate that treatment with inhibitors of EZH2 or BET may be an effective therapy for diffuse intrinsic pontine glioma.